The goal of this project is to develop an initial verification of a new method for the treatment of multiple sclerosis (MS), an autoimmune disease. About 900-1000 people are diagnosed with MS every year in Sweden. Current treatments are ineffective and often not specific for MS, and can lead to undesirable consequences, sometimes fatal. A vaccine that inhibits the development of MS, or even cures the disease at an early stage, would be revolutionary for Swedish and international drug development.
Menu